trimethoprim--sulfamethoxazole-drug-combination and Hepatic-Encephalopathy

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Hepatic-Encephalopathy* in 3 studies

Reviews

1 review(s) available for trimethoprim--sulfamethoxazole-drug-combination and Hepatic-Encephalopathy

ArticleYear
Acute fulminant hepatic failure in a woman treated with phenytoin and trimethoprim-sulfamethoxazole.
    Archives of pathology & laboratory medicine, 2000, Volume: 124, Issue:12

    Massive hepatic necrosis following exposure to phenytoin and trimethoprim-sulfamethoxazole is a rare occurrence and to the best of our knowledge has not been reported previously. Acute hepatic failure following administration of trimethoprim-sulfamethoxazole has rarely been seen, and only 4 cases have been well documented pathologically. We report a case of acute liver failure in a 60-year-old woman following ingestion of phenytoin and trimethoprim-sulfamethoxazole concomitantly over a 9-day period. Autopsy findings revealed acute fulminant hepatic failure. This case demonstrates the effects of chemical-chemical interactions in the potentiation of hepatotoxicity of single agents and specifically illustrates the need for discontinuing trimethoprim-sulfamethoxazole in the presence of early liver injury.

    Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Child, Preschool; Drug Interactions; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Liver; Middle Aged; Necrosis; Phenytoin; Trimethoprim, Sulfamethoxazole Drug Combination

2000

Other Studies

2 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Hepatic-Encephalopathy

ArticleYear
Fulminant hepatic failure in a child as a potential adverse effect of trimethoprim-sulphamethoxazole.
    European journal of pediatrics, 1995, Volume: 154, Issue:7

    Trimethoprim-sulphamethoxazole (TMP-SMZ) is considered a safe drug for treatment of infectious bacterial diseases in children. Side-effects are rare and generally take the form of a hypersensitivity reaction to the sulphamethoxazole component of the drug. Hepatic injury usually presents as a transient elevation of liver enzymes, which is of little clinical relevance. Fulminant liver failure due to TMP-SMZ has been reported in only six adults and never in children. We here report a 5-year-old girl who developed fulminant liver failure 3 weeks after her third exposure to TMP-SMZ. After a biphasic clinical course she underwent successful liver transplantation.. Trimethoprim-Sulphamethoxazole may cause fulminant liver failure in children. The disease can run a biphasic clinical course and liver transplantation must be considered as the therapeutic option for these patients.

    Topics: Biopsy; Child, Preschool; Escherichia coli Infections; Female; Hepatic Encephalopathy; Humans; Liver; Liver Function Tests; Liver Transplantation; Recurrence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

1995
[Acute liver failure and severe cholestasis due to sulfonamides].
    Casopis lekaru ceskych, 1985, Feb-08, Volume: 124, Issue:6

    Topics: Adult; Chemical and Drug Induced Liver Injury; Cholestasis; Drug Combinations; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Sulfamethoxazole; Sulfonamides; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination

1985